Melkor
☆    

Greece,
2015-10-11 21:49
(3109 d 08:14 ago)

Posting: # 15551
Views: 2,247
 

 MHRA regulatory issue [Regulatives / Guidelines]

Post reply
Greetings,

I was wondering what are the requirements for a variation in MHRA for change of FDF manufacturer for a oral liquid product. I guess that a process validation is essential is it though also a minimum stability data required in order to proceed with the submission of the variation?

Thank you :-)
 
UA Flag
Activity
 Admin contact
22,984 posts in 4,822 threads, 1,651 registered users;
44 visitors (0 registered, 44 guests [including 5 identified bots]).
Forum time: 06:03 CEST (Europe/Vienna)

You can’t fix by analysis
what you bungled by design.    Richard J. Light, Judith D. Singer, John B. Willett

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5